Possible explanation:

Options trading is a way of betting on how the price of a stock will change. People can buy or sell contracts that give them the right to buy or sell a certain number of shares at a fixed price, called the strike price, within a specific time period. This article talks about Viking Therapeutics, a company that makes medicines for various diseases. Some people are betting that the stock price of this company will go down, so they buy contracts that give them the right to sell the shares at a higher price than the current market price. These contracts are called puts. Other people think the opposite and buy contracts that give them the right to buy the shares at a lower price than the current market price. These contracts are called calls.

The article also mentions some large transactions, or trades, involving these options contracts. Some of these trades involve very high amounts of money, which indicates that the people making them have a lot of confidence in their predictions. The article uses charts and numbers to show how many contracts were bought or sold for different strike prices over the last 30 days. This helps us understand what price range most people are betting on for Viking Therapeutics' stock.

Summary:

This article is about people who are guessing whether the stock price of a company called Viking Therapeutics will go up or down. They use something called options trading to make these guesses. The article shows us some big trades that happened and what price range most people are betting on for the stock. Read from source...

The title of the article is misleading and does not accurately represent the content. The article focuses on the options trading trends in Viking Therapeutics, but it does not provide any insights into why these trends are occurring or what factors are driving them. The article also lacks any analysis of the implications of these trends for the company and its investors.

The article relies heavily on data from Benzinga, which is a financial news platform that provides information on stocks, options, and other securities. However, the article does not acknowledge the limitations or potential biases of this data source, such as the fact that it may not be representative of the entire market or that it may be subject to manipulation by traders or other actors.

The article uses technical terms and concepts without explaining them clearly or providing any context for readers who may not be familiar with options trading. For example, the article mentions "open interest" and "volume," but does not define these terms or explain how they are calculated or interpreted. This makes it difficult for readers to understand the meaning and significance of these metrics.

The article also contains several errors and inconsistencies that undermine its credibility. For example, the article states that there are 13 options contracts linked to Viking Therapeutics, but then goes on to describe 20 different trades. This is a contradiction that suggests either a lack of careful fact-checking or an attempt to mislead readers. Additionally, the article refers to "whales" as if this is a well-defined and agreed-upon term, but it does not provide any explanation or definition for who these whales are or how they are identified.

The article concludes with a promotional message for Benzinga Pro, which is a paid service that offers real-time alerts on options trades. This is an inappropriate and unethical use of the author's platform to advertise a product that may not be relevant or useful to readers.

Overall, the article is poorly written, lacks substance, and contains numerous errors and inconsistencies. It does not provide any valuable insights into the options trading trends in Viking Therapeutics, and it appears to be more of a promotional piece for Benzinga than an informative or analytical article.

The sentiment of the article is bullish.

As an AI model that can do anything now, I have carefully analyzed the article titled "Unpacking the Latest Options Trading Trends in Viking Therapeutics" and generated a comprehensive set of investment recommendations and risks for you. Here they are:

Recommendation 1: Buy a bull call spread on Viking Therapeutics with a strike price of $15.0 and an expiration date of May 21, 2021. This strategy involves buying a call option with a strike price of $15.0 and selling another call option with a strike price of $20.0 for the same amount of contracts. The goal is to benefit from a rise in the stock price within this range while limiting your potential loss and cost.

Risk: If the stock price drops below $15.0, you will lose the premium paid for the call option that was sold, or $5.0 per contract. This strategy is suitable for investors who are bullish on Viking Therapeutics in the short term and expect it to trade between $15.0 and $20.0 by May 21, 2021.

Recommendation 2: Sell a bear put spread on Viking Therapeutics with a strike price of $8.0 and an expiration date of May 21, 2021. This strategy involves selling a put option with a strike price of $8.0 and buying another put option with a strike price of $5.0 for the same amount of contracts. The goal is to benefit from a decline in the stock price within this range while limiting your potential loss and cost.

Risk: If the stock price rises above $8.0, you will lose the premium received for the put option that was sold, or $3.0 per contract. This strategy is suitable for investors who are bearish on Viking Therapeutics in the short term and expect it to trade below $8.0 by May 21, 2021.